These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1495828)

  • 41. In-vitro effects of vancomycin, rifampicin, and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcus aureus.
    Foldes M; Munro R; Sorrell TC; Shanker S; Toohey M
    J Antimicrob Chemother; 1983 Jan; 11(1):21-6. PubMed ID: 6826485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cephalosporins, vancomycin, aminoglycosides and other drugs, especially in combination, for the treatment of methicillin-resistant staphylococcal infections.
    Klastersky J; Van der Auwera P
    J Antimicrob Chemother; 1986 Mar; 17 Suppl A():19-24. PubMed ID: 2940212
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fusidic acid in the treatment of methicillin-resistant Staphylococcus aureus.
    Whitby M
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S67-71. PubMed ID: 10528788
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In-vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus.
    Drugeon HB; Caillon J; Juvin ME
    J Antimicrob Chemother; 1994 Dec; 34(6):899-907. PubMed ID: 7730233
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Resistance to fusidic acid.
    Turnidge J; Collignon P
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S35-44. PubMed ID: 10528785
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Serum pharmacokinetics and in vitro antibacterial activity of pefloxacin, ofloxacin and ciprofloxacin].
    Nordmann P; Jarlier V
    Presse Med; 1990 Sep 1-8; 19(28):1321-5. PubMed ID: 2145562
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Refractory respiratory tract infections. 6. New problems in refractory respiratory tract infections. c. Chemotherapy of methicillin-resistant Staphylococci infection].
    Konno M
    Nihon Rinsho; 1987 Mar; 45(3):565-70. PubMed ID: 3298734
    [No Abstract]   [Full Text] [Related]  

  • 48. Comparison of the in vitro activities of delafloxacin and comparators against Staphylococcus epidermidis clinical strains involved in osteoarticular infections: a CRIOGO multicentre retrospective study.
    Tessier E; Ruffier d'Epenoux L; Lartigue MF; Chaufour L; Plouzeau-Jayle C; Chenouard R; Guérin F; Tandé D; Lamoureux C; Bémer P; Corvec S;
    J Antimicrob Chemother; 2024 May; 79(5):1045-1050. PubMed ID: 38507272
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fusidic acid in orthopaedic infections due to coagulase-negative staphylococci.
    Coombs RR; Menday AP
    Curr Med Res Opin; 1985; 9(9):587-90. PubMed ID: 3902374
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In-vitro activity of ciprofloxacin combined with either fusidic acid or rifampicin against Staphylococcus aureus.
    Røder BL; Gutschik E
    J Antimicrob Chemother; 1989 Mar; 23(3):347-52. PubMed ID: 2732119
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The activity of ofloxacin against methicillin-resistant Staphylococcus aureus.
    Mraović M; Canić-Radojlović M
    Infection; 1986; 14 Suppl 4():S231-2. PubMed ID: 3469151
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A nutrient medium for the isolation of staphylococci with persistence characteristics].
    Bukharin OV; Matiushina SB; Chernova OL
    Klin Lab Diagn; 1999 Aug; (8):35-7. PubMed ID: 10544569
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Failure of combination therapy for Staphylococcus aureus bone infection: a case of in vivo selection with resistance to rifampicin and fusidic acid.
    Aubin GG; Bémer P; Guillouzouic A; Launay E; Geffroy L; Touchais S; Corvec S
    Infect Dis (Lond); 2016 Sep; 48(9):699-702. PubMed ID: 27194514
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Killing effects of antibiotics and two-fold antimicrobial combinations on proliferating and non growing staphylococci.
    Schierholz JM; Beuth J; Pulverer G
    Zentralbl Bakteriol; 1998 Dec; 288(4):527-39. PubMed ID: 9987191
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis.
    Dworkin R; Modin G; Kunz S; Rich R; Zak O; Sande M
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1014-6. PubMed ID: 2393259
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of antibiotic resistance to orally administrable antibiotics in staphylococcal bone and joint infections in one of the largest university hospitals in Germany: is there a role for fusidic acid?
    Klein S; Nurjadi D; Eigenbrod T; Bode KA
    Int J Antimicrob Agents; 2016 Feb; 47(2):155-7. PubMed ID: 26774158
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparative study between teicoplanin alone and flucloxacillin, plus or minus fusidic acid, in the treatment of serious infections caused by methicillin-susceptible gram-positive bacteria.
    Mehtar S; Drabu Y; Wilson AP; Grüneberg RN
    Chemotherapy; 1995; 41(5):412-9. PubMed ID: 8521744
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The post-antibiotic effect of teicoplanin: monotherapy and combination studies.
    Drabu YJ; Blakemore PH
    J Antimicrob Chemother; 1991 Apr; 27 Suppl B():1-7. PubMed ID: 1829074
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro activity of ciprofloxacin against methicillin-susceptible and methicillin-resistant staphylococci.
    Gahrn-Hansen B; Søgaard P; Arpi M
    Eur J Clin Microbiol; 1987 Oct; 6(5):581-4. PubMed ID: 3436320
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of fusidic acid on staphylococcal keratitis.
    Tabbara KF; Antonios S; Alvarez H
    Br J Ophthalmol; 1989 Feb; 73(2):136-9. PubMed ID: 2649148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.